Literature DB >> 25067827

RELN-expressing neuron density in layer I of the superior temporal lobe is similar in human brains with autism and in age-matched controls.

Jasmin Camacho1, Ehsan Ejaz1, Jeanelle Ariza1, Stephen C Noctor2, Verónica Martínez-Cerdeño3.   

Abstract

Reelin protein (RELN) level is reduced in the cerebral cortex and cerebellum of subjects with autism. RELN is synthesized and secreted by a subpopulation of neurons in the developing cerebral cortex termed Cajal-Retzius (CR) cells. These cells are abundant in the marginal zone during cortical development, many die after development is complete, but a small population persists into adulthood. In adult brains, RELN is secreted by the surviving CR cells, by a subset of GABAergic interneurons in layer I, and by pyramidal cells and GABAergic interneurons in deeper cortical layers. It is widely believed that decreased RELN in layer I of the cerebral cortex of subjects with autism may result from a decrease in the density of RELN expressing neurons in layer I; however, this hypothesis has not been tested. We examined RELN expression in layer I of the adult human cortex and found that 70% of cells express RELN in both control and autistic subjects. We quantified the density of neurons in layer I of the superior temporal cortex of subjects with autism and age-matched control subjects. Our data show that there is no change in the density of neurons in layer I of the cortex of subjects with autism, and therefore suggest that reduced RELN expression in the cerebral cortex of subjects with autism is not a consequence of decreased numbers of RELN-expressing neurons in layer I. Instead reduced RELN may result from abnormal RELN processing, or a decrease in the number of other RELN-expressing neuronal cell types.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autism; Cajal–Retzius cells; Layer I; Postmortem; Reelin; Superior temporal cortex

Mesh:

Substances:

Year:  2014        PMID: 25067827      PMCID: PMC4324637          DOI: 10.1016/j.neulet.2014.07.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

1.  Novel calretinin and reelin expressing neuronal population includes Cajal-Retzius-type cells in the neocortex of adult pigs.

Authors:  H Abrahám; Z Tóth; F Bari; F Domoki; L Seress
Journal:  Neuroscience       Date:  2005-09-21       Impact factor: 3.590

2.  Reelin immunoreactivity in the adult primate brain: intracellular localization in projecting and local circuit neurons of the cerebral cortex, hippocampus and subcortical regions.

Authors:  Verónica Martínez-Cerdeño; María José Galazo; Carmen Cavada; Francisco Clascá
Journal:  Cereb Cortex       Date:  2002-12       Impact factor: 5.357

3.  Reelin immunoreactivity in the adult neocortex: a comparative study in rodents, carnivores, and non-human primates.

Authors:  Verónica Martínez-Cerdeño; Francisco Clascá
Journal:  Brain Res Bull       Date:  2002 Feb-Mar 1       Impact factor: 4.077

4.  Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression.

Authors:  C Pesold; W S Liu; A Guidotti; E Costa; H J Caruncho
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Ultrastructural localization of reelin in the cortex in post-mortem human brain.

Authors:  Rosalinda C Roberts; Leyan Xu; Joy K Roche; Brian Kirkpatrick
Journal:  J Comp Neurol       Date:  2005-02-14       Impact factor: 3.215

6.  Calretinin-positive Cajal-Retzius cells persist in the adult human neocortex.

Authors:  P V Belichenko; D M Vogt Weisenhorn; J Myklóssy; M R Celio
Journal:  Neuroreport       Date:  1995-10-02       Impact factor: 1.837

7.  Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease.

Authors:  Anett Riedel; Riitta Miettinen; Jens Stieler; Mia Mikkonen; Irina Alafuzoff; Hilkka Soininen; Thomas Arendt
Journal:  Acta Neuropathol       Date:  2003-06-17       Impact factor: 17.088

8.  Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder.

Authors:  S Hossein Fatemi; Joel M Stary; Elizabeth Ann Egan
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

9.  Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder.

Authors:  A M Persico; L D'Agruma; N Maiorano; A Totaro; R Militerni; C Bravaccio; T H Wassink; C Schneider; R Melmed; S Trillo; F Montecchi; M Palermo; T Pascucci; S Puglisi-Allegra; K L Reichelt; M Conciatori; R Marino; C C Quattrocchi; A Baldi; L Zelante; P Gasparini; F Keller
Journal:  Mol Psychiatry       Date:  2001-03       Impact factor: 15.992

10.  Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons.

Authors:  Goichi Miyoshi; Jens Hjerling-Leffler; Theofanis Karayannis; Vitor H Sousa; Simon J B Butt; James Battiste; Jane E Johnson; Robert P Machold; Gord Fishell
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.709

View more
  10 in total

Review 1.  Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models.

Authors:  Verónica Martínez-Cerdeño
Journal:  Dev Neurobiol       Date:  2016-08-30       Impact factor: 3.964

2.  The Number of Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism.

Authors:  Ezzat Hashemi; Jeanelle Ariza; Haille Rogers; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

3.  Preliminary findings suggest the number and volume of supragranular and infragranular pyramidal neurons are similar in the anterior superior temporal area of control subjects and subjects with autism.

Authors:  Esther Kim; Jasmin Camacho; Zachary Combs; Jeanelle Ariza; Mirna Lechpammer; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Neurosci Lett       Date:  2015-01-09       Impact factor: 3.046

Review 4.  Autism spectrum disorder: neuropathology and animal models.

Authors:  Merina Varghese; Neha Keshav; Sarah Jacot-Descombes; Tahia Warda; Bridget Wicinski; Dara L Dickstein; Hala Harony-Nicolas; Silvia De Rubeis; Elodie Drapeau; Joseph D Buxbaum; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2017-06-05       Impact factor: 17.088

5.  Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Mohammad Qasaymeh; Shadi Qasem; Emily De Los Reyes
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-16       Impact factor: 2.570

6.  Maternal Exposure to Valproic Acid Primarily Targets Interneurons Followed by Late Effects on Neurogenesis in the Hippocampal Dentate Gyrus in Rat Offspring.

Authors:  Yousuke Watanabe; Tomoaki Murakami; Masashi Kawashima; Yasuko Hasegawa-Baba; Sayaka Mizukami; Nobuya Imatanaka; Yumi Akahori; Toshinori Yoshida; Makoto Shibutani
Journal:  Neurotox Res       Date:  2016-08-26       Impact factor: 3.911

7.  Maximizing Explanatory Power in Stereological Data Collection: A Protocol for Reliably Integrating Optical Fractionator and Multiple Immunofluorescence Techniques.

Authors:  Anna Kreutz; Nicole Barger
Journal:  Front Neuroanat       Date:  2018-10-30       Impact factor: 3.856

8.  Postnatal development and maturation of layer 1 in the lateral prefrontal cortex and its disruption in autism.

Authors:  Iris Margalit Trutzer; Miguel Ángel García-Cabezas; Basilis Zikopoulos
Journal:  Acta Neuropathol Commun       Date:  2019-03-13       Impact factor: 7.801

Review 9.  The Reeler Mouse: A Translational Model of Human Neurological Conditions, or Simply a Good Tool for Better Understanding Neurodevelopment?

Authors:  Laura Lossi; Claudia Castagna; Alberto Granato; Adalberto Merighi
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

10.  Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Emily De Los Reyes
Journal:  Children (Basel)       Date:  2021-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.